Drug Trial Radar · NCT02927067
A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants
Last checked: Nov 19, 2026Latest source record: Mar 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
553
Actual
Start
Apr 14, 2017
Primary completion
Jul 1, 2022
Study completion Jul 1, 2022
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- Collaborators
- Takeda Development Center Americas, Inc.
- First posted
- Oct 6, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is about treatment options for cytomegalovirus infections in people who have received stem cell transplants. The main aim of the study is to check if the cytomegalovirus infection can no longer be detected after treatment with marivabir or valganciclovir. Participants will take 2 tablets of marivabir or valganciclovir and 2 tablets of placebo twice a day for 8 weeks. A placebo will look like marivabir or valganciclovir but will not have any medicine in it. After treatment, each participant will be followed up for up to 12 weeks. Participants will visit their study clinic up to 18 times during the study.
Conditions
- Cytomegalovirus (CMV)
Interventions
MaribavirDrug
Participants will receive 400 mg of maribavir BID orally.
ValganciclovirDrug
Participants will receive valganciclovir tablets orally.
PlaceboOther
Participants will receive placebo tablets matched to either maribavir or valganciclovir.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Who Achieved Confirmed Clearance of Plasma Cytomegalovirus (CMV) Deoxyribose Nucleic Acid (DNA) at the End of Study Week 8Time frame: Week 8
Locations
129 sites in 23 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
UCLA Medical Center
Los Angeles, California
Stanford University
Stanford, California
Colorado Blood Cancer Institute - PPDS
Denver, Colorado
Yale University School of Medicine
New Haven, Connecticut
Emory University
Atlanta, Georgia
University of Chicago
Chicago, Illinois
Loyola University Medical Center
Maywood, Illinois
University of Maryland School of Medicine
Baltimore, Maryland
Johns Hopkins Hospital
Baltimore, Maryland
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Brigham and Womens Hospital
Boston, Massachusetts
UMass Memorial Medical Center
Worcester, Massachusetts
Harper University Hospital
Detroit, Michigan
Henry Ford Health System
Detroit, Michigan
University of Minnesota
Minneapolis, Minnesota
Mayo Clinic - PIN
Rochester, Minnesota
Hackensack University Medical Center
Hackensack, New Jersey
Joan and sandford I. Weill Medical College of Cornell University Clinic
New York, New York
Columbia University Medical Center
New York, New York
Memorial Sloan Kettering Cancer Center
New York, New York
University of Pennsylvania
Philadelphia, Pennsylvania
TriStar Centennial Medical Center
Nashville, Tennessee
Saint Davids South Austin Medical Center
Austin, Texas
University of Texas MD Anderson Cancer Center
Houston, Texas
Texas Transplant Institute
San Antonio, Texas
VA Puget Sound Health Care System - NAVREF - PPDS
Seattle, Washington
The Medical College of Wisconsin, Inc.
Milwaukee, Wisconsin
Westmead Hospital
Westmead, New South Wales, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Royal Melbourne Hospital
Parkville, Victoria, Australia
Elisabethinen Hospital Linz
Linz, Austria
Medizinische Universitat Wien (Medical University of Vienna)
Vienna, State of Vienna, Austria
CHU de Liège
Liège, Belgium
UZ Antwerpen
Edegem, Antwerpen, Belgium
Institute Jules Bordet
Brussels, Brussels Capital, Belgium
Cliniques Universitaires Saint-Luc
Brussels, Brussels Capital, Belgium
Universitair Ziekenhuis Brussel - PIN
Jette, Brussels Capital, Belgium
University Hospital Gent
Ghent, Oost-Vlaanderen, Belgium
UZ Leuven
Leuven, Vlaams Brabant, Belgium
Showing 40 of 129 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.